Related Experiment Videos
Prophylaxis for recurrent acute otitis media: a Brazilian study
1Department of Otolaryngology, Faculdade de Medicina, Universidade de Sao Paulo, Brasil.
International Journal of Pediatric Otorhinolaryngology
|January 1, 1993
Summary
Antimicrobial prophylaxis significantly reduces recurrent acute otitis media (AOM) in children. Both trimethoprim-sulfamethoxazole and amoxicillin were equally effective, suggesting the less expensive option is preferable.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pharmacology
Background:
- Recurrent acute otitis media (AOM) is a common childhood infection.
- Antimicrobial prophylaxis is a potential strategy to reduce AOM recurrence.
- Previous studies have shown mixed results on the efficacy of prophylaxis.
Purpose of the Study:
- To evaluate the effectiveness of antimicrobial prophylaxis in preventing recurrent AOM in children.
- To compare the efficacy of trimethoprim-sulfamethoxazole (TMP-SMX) and amoxicillin (AMX) for AOM prophylaxis.
- To determine if prophylaxis influences the timing of AOM recurrence.
Main Methods:
- A randomized controlled trial involving 60 children with recurrent AOM.
- Children received either TMP-SMX, AMX, or placebo (PLA) once daily for 3 months at 1/3 therapeutic dose.
- Pneumootoscopy and impedance tympanometry (TYMP) were used for monthly evaluations and during acute illness.
Main Results:
- A significantly higher rate of recurrent AOM was observed in the placebo group (50%) compared to antibiotic groups (17%, P < 0.005).
- Both TMP-SMX (20% recurrence) and AMX (15% recurrence) were equally effective in preventing recurrent AOM.
- Recurrences in the placebo group occurred earlier than in the antibiotic prophylaxis groups.
Conclusions:
- Antimicrobial prophylaxis is effective in reducing the incidence of recurrent AOM in children.
- TMP-SMX and AMX demonstrate similar efficacy for preventing recurrent AOM.
- The findings support the use of antimicrobial prophylaxis, with cost-effectiveness favoring the less expensive agent.